Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival. [electronic resource]
Producer: 20160701Description: 643 p. digitalISSN:- 1471-2407
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lung Neoplasms -- genetics
- Male
- Middle Aged
- Neoplasm Metastasis
- Neovascularization, Pathologic -- drug therapy
- Receptor, Notch1 -- biosynthesis
- Vascular Endothelial Growth Factor Receptor-1 -- biosynthesis
- Vascular Endothelial Growth Factor Receptor-3 -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.